Suivi thérapeutique pharmacologique de l’éthosuximide

Manning, 2003, Pharmacology of absence epilepsy, Trends Pharmacol Sci, 24, 542, 10.1016/j.tips.2003.08.006

Striano, 2010, Epilepsy: old drugs do the trick in childhood absence epilepsy, Nat Rev Neurol, 6, 420, 10.1038/nrneurol.2010.106

Penovich, 2009, Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy, Epilepsia, 50, 37, 10.1111/j.1528-1167.2009.02234.x

Potera, 2010, An older drug for childhood absence epilepsy, Am J Nurs, 110, 16

Fiumara, 2010, Epilepsy in patients with Angelman syndrome, Ital J Pediatr, 36, 31, 10.1186/1824-7288-36-31

Barton, 2005, The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil, Eur J Pharmacol, 521, 79, 10.1016/j.ejphar.2005.08.017

Goulet, 1976, Metabolism of ethosuximide, Clin Pharmacol Ther, 20, 213, 10.1002/cpt1976202213

Eadie, 1977, Pharmacokinetics of drugs used for petit mal “absence” epilepsy, Clin Exp Neurol, 14, 172

Buchanan, 1973, The absorption and excretion of ethosuximide, Int J Clin Pharmacol, 7, 213

Bauer, 1982, Ethosuximide kinetics: possible interaction with valproic acid, Clin Pharmacol Ther, 31, 741, 10.1038/clpt.1982.104

Buchanan, 1969, Absorption and elimination of ethosuximide in children, J Clin Pharmacol J New Drugs, 9, 393, 10.1177/009127006900900607

Kuhnz, 1984, Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status, Br J Clin Pharmacol, 18, 671, 10.1111/j.1365-2125.1984.tb02528.x

Bachmann, 2003, Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes, Xenobiotica, 33, 265, 10.1080/0049825021000061606

Goren, 2007, Ethosuximide: from bench to bedside, CNS Drug Rev, 13, 224, 10.1111/j.1527-3458.2007.00009.x

Villen, 1990, Nonstereoselective disposition of ethosuximide in humans, Ther Drug Monit, 12, 514, 10.1097/00007691-199009000-00018

Haerer, 1970, Ethosuximide blood levels in epileptics, J Clin Pharmacol J New Drugs, 10, 370, 10.1177/009127007001000602

Stephenson, 1974, Proceedings: Plasma ethosuximide in epilepsy: clinical aid and illustration of principles, Arch Dis Child, 49, 412, 10.1136/adc.49.5.412-b

Sherwin, 1973, Improved control of epilepsy by monitoring plasma ethosuximide, Arch Neurol, 28, 178, 10.1001/archneur.1973.00490210058007

Browne, 1975, Ethosuximide in the treatment of absence (petit mal) seizures, Neurology, 25, 515, 10.1212/WNL.25.6.515

Smith, 1979, Factors influencing plasma concentrations of ethosuximide, Clin Pharmacokinet, 4, 38, 10.2165/00003088-197904010-00004

Battino, 1982, Ethosuximide plasma concentrations: influence of age and associated concomitant therapy, Clin Pharmacokinet, 7, 176, 10.2165/00003088-198207020-00006

Salke-Kellermann, 1997, Influence of ethosuximide on valproic acid serum concentrations, Epilepsy Res, 26, 345, 10.1016/S0920-1211(96)01001-7

Dawson, 1978, Serum phenytoin after ethosuximide, Ann Neurol, 4, 583, 10.1002/ana.410040629

Giaccone, 1996, Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients, Br J Clin Pharmacol, 41, 575, 10.1046/j.1365-2125.1996.03601.x

Pisani, 1984, Valproic acid-ethosuximide interaction: a pharmacokinetic study, Epilepsia, 25, 229, 10.1111/j.1528-1157.1984.tb04180.x

Mattson, 1980, Valproic acid and ethosuximide interaction, Ann Neurol, 7, 583, 10.1002/ana.410070613

Eriksson, 1996, Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy, Epilepsia, 37, 769, 10.1111/j.1528-1157.1996.tb00650.x

van Wieringen, 1983, Ethosuximide intoxication caused by interaction with isoniazid, Neurology, 33, 1227, 10.1212/WNL.33.9.1227

Manfredi, 1982, Simplified gas chromatography of valproic acid and ethosuximide, Clin Chem, 28, 246, 10.1093/clinchem/28.1.246a

Zawisza, 1992, High-performance liquid chromatographic determination of ethosuximide in plasma, Acta Pol Pharm, 49, 7

Turnell, 1983, A rapid procedure for the simultaneous estimation of the anticonvulsant drugs, ethosuximide, phenobarbitone, phenytoin, and carbamazepine in serum using high-pressure liquid chromatography, Ann Clin Biochem, 20, 37, 10.1177/000456328302000106

Matar, 1999, Liquid chromatographic determination of six antiepileptic drugs and two metabolites in microsamples of human plasma, Ther Drug Monit, 21, 559, 10.1097/00007691-199910000-00013

Szabo, 1982, Improved isocratic liquid-chromatographic simultaneous measurement of phenytoin, phenobarbital, primidone, carbamazepine, ethosuximide, and N-desmethylmethsuximide in serum, Clin Chem, 28, 100, 10.1093/clinchem/28.1.100

Chan, 1984, The simultaneous determination of five anti-epileptic drugs in plasma by high performance liquid chromatography, Methods Find Exp Clin Pharmacol, 6, 701

Kuhnz, 1984, Automated high-pressure liquid chromatographic assay for antiepileptic drugs and their major metabolites by direct injection of serum samples, Ther Drug Monit, 6, 478, 10.1097/00007691-198412000-00019

Neels, 1983, Simultaneous high performance liquid-chromatographic determination of carbamazepine, carbamazepine-10,11-epoxide, ethosuximide, phenobarbital, phenytoin, primidone and phenylethylmalonamide in plasma, J Clin Chem Clin Biochem, 21, 295

Ou, 1984, Simultaneous measurement of ethosuximide, primidone, phenobarbital, phenytoin, carbamazepine, and their bioactive metabolites by liquid chromatography, Clin Chem, 30, 1667, 10.1093/clinchem/30.10.1667

Wad, 1984, Simultaneous determination of eleven antiepileptic compounds in serum by high-performance liquid chromatography, J Chromatogr, 305, 127, 10.1016/S0378-4347(00)83320-4

Bhatt, 2010, Development of a high-throughput method for the determination of ethosuximide in human plasma by liquid chromatography mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci, 878, 1605, 10.1016/j.jchromb.2010.03.019

Patsalos, 2008, Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies, Epilepsia, 49, 1239, 10.1111/j.1528-1167.2008.01561.x